Basso Capital Management’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Basso Capital Management’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-55,288	Closed	-$557K	–	316
2022 Q3	$557K	Buy	+55,288	New	+$555K	0.13%	166
2022 Q2	–	Sell	-5,288	Closed	-$53K	–	675
2022 Q1	$53K	Buy	+5,288	New	+$52.5K	0.01%	483

Other funds holding IQMD

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

HIM

HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Basso Capital Management's IQMD Position: Q4 2022 in Review

Basso Capital Management sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q4 2022, closing a stake of 55,288 shares — an estimated $557K sold.

Basso Capital Management first reported a position in IQMD in Q1 2022 and held it in 2 quarters. The position peaked at $557K in Q3 2022. 60 funds tracked by Wall St. Rank hold IQMD as of Q4 2022.

Basso Capital Management reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Basso Capital Management sold 55,288 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $557K.
Basso Capital Management first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 2 quarters.
Basso Capital Management's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $557K in Q3 2022.
60 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Basso Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.